OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study
R Naveen, Elena Nikiphorou, Mrudula Joshi, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 7, pp. 2453-2463
Open Access | Times Cited: 15

Showing 15 citing articles:

Systemic Lupus Erythematosus and COVID-19
Μαρία Παππά, Alexandros Panagiotopoulos, Κonstantinos Thomas, et al.
Current Rheumatology Reports (2023) Vol. 25, Iss. 10, pp. 192-203
Open Access | Times Cited: 11

COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosus
Nefeli Giannopoulou, Latika Gupta, Laura Andréoli, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103292-103292
Open Access | Times Cited: 5

COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey
Mrinalini Dey, Bohdana Doskaliuk, Ioannis Parodis, et al.
Rheumatology International (2024)
Open Access | Times Cited: 1

Vaccination updates and special considerations for systemic lupus erythematosus patients
Jammie Law, Cristina Sorrento, Amit Saxena
Current Opinion in Rheumatology (2023) Vol. 36, Iss. 2, pp. 148-153
Closed Access | Times Cited: 4

COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus
Mrinalini Dey, Bohdana Doskaliuk, Julius Lindblom, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7542-7542
Open Access | Times Cited: 4

Autoimmune rheumatic diseases and COVID-19 vaccination: a retrospective cross-sectional study from Astana
Kristina Rutskaya-Moroshan, Saule Abisheva, Madina Sarsenova, et al.
Reumatologia/Rheumatology (2024) Vol. 62, Iss. 1, pp. 26-34
Open Access | Times Cited: 1

Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination
Ji-Won Kim, Ju‐Yang Jung, Chang‐Hee Suh, et al.
Journal of Korean Medical Science (2023) Vol. 38, Iss. 32
Open Access | Times Cited: 3

Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey
Sakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International (2023) Vol. 44, Iss. 1, pp. 89-97
Closed Access | Times Cited: 2

Seguridad de la vacunación COVID-19 en una muestra de pacientes brasileños con lupus eritematoso sistémico
Bianca Lins Alencar, Valentina Busato, Renato Nisihara, et al.
Revista Argentina de Reumatología (2024) Vol. 35, Iss. 1, pp. 11-16
Open Access

Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study
Leonardo Palazzo, Julius Lindblom, Emelie Kihlgren Olsson, et al.
Rheumatology International (2024) Vol. 44, Iss. 10, pp. 1923-1933
Open Access

Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review
Preeti Dhanasekaran, Biraveena Thirunavuc Karasu, Anselm Mak
Rheumatology International (2024)
Closed Access

COVID‐19 Vaccination in Patients With Systemic Lupus Erythematosus: Adverse Events and Rating Agreement of Flares Between Patients and Physicians
Punsita Tangkum, Nuntana Kasitanon, Wanitcha Gumtorntip, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 12
Closed Access

COVID-19 vaccines safe in patients with systemic lupus erythematosus

Reactions Weekly (2022) Vol. 1935, Iss. 1, pp. 9-9
Closed Access

Page 1

Scroll to top